Fig. 5From: A simple self-assembling system of melittin for hepatoma treatmentViability (A) and apoptosis analysis (B) of HepG2 cells after treatment with melittin or M/VG nanoparticles for 48Â h. Motility (C) and quantitative analysis of healing rate for melittin or M/VG nanoparticles (D)Back to article page